Blackman Samuel C. has filed 43 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 30000 shares of Day One Biopharmaceuticals, Inc. ($DAWN) on December 10, 2024.
Activity breakdown: 0 open-market purchases and 17 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 10, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 30000 | $13.31 | 2,034,015.0000 | 96,937,759 | 1.45% | 0.03% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 1187 | $0.00 | 2,058,722.0000 | 96,937,759 | 0.06% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 1437 | $0.00 | 2,060,159.0000 | 96,937,759 | 0.07% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 6062 | $0.00 | 2,066,221.0000 | 96,937,759 | 0.29% | 0.01% |
| Nov. 18, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 2206 | $13.21 | 2,064,015.0000 | 96,937,759 | 0.11% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 1187 | $0.00 | 4,756.0000 | 96,937,759 | 19.97% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 1437 | $0.00 | 11,504.0000 | 96,937,759 | 11.10% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 6062 | $0.00 | 72,752.0000 | 96,937,759 | 7.69% | 0.01% |
| Nov. 8, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 18255 | $16.17 | 2,067,535.0000 | 96,937,759 | 0.88% | 0.02% |
| Nov. 11, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 10000 | $16.10 | 2,057,535.0000 | 96,937,759 | 0.48% | 0.01% |
| Nov. 7, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 11245 | $16.03 | 2,085,790.0000 | 96,937,759 | 0.54% | 0.01% |
| Oct. 31, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 500 | $16.02 | 2,097,035.0000 | 96,937,759 | 0.02% | 0.00% |
| Sept. 10, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 30000 | $14.22 | 2,097,535.0000 | 79,773,004 | 1.41% | 0.04% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 1187 | $0.00 | 2,122,268.0000 | 79,773,004 | 0.06% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 1437 | $0.00 | 2,123,705.0000 | 79,773,004 | 0.07% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 6062 | $0.00 | 2,129,767.0000 | 79,773,004 | 0.29% | 0.01% |
| Aug. 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 2232 | $14.00 | 2,127,535.0000 | 79,773,004 | 0.10% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 1187 | $0.00 | 5,943.0000 | 79,773,004 | 16.65% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 1437 | $0.00 | 12,941.0000 | 79,773,004 | 9.99% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 6062 | $0.00 | 78,814.0000 | 79,773,004 | 7.14% | 0.01% |
| July 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 20000 | $16.01 | 2,121,081.0000 | 79,773,004 | 0.93% | 0.03% |
| June 10, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 30000 | $12.62 | 2,141,081.0000 | 79,773,004 | 1.38% | 0.04% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 1187 | $0.00 | 2,165,849.0000 | 79,773,004 | 0.05% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 1437 | $0.00 | 2,167,286.0000 | 79,773,004 | 0.07% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Common Stock | 6062 | $0.00 | 2,173,348.0000 | 79,773,004 | 0.28% | 0.01% |
| May 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 2267 | $16.08 | 2,171,081.0000 | 79,773,004 | 0.10% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 1187 | $0.00 | 7,130.0000 | 79,773,004 | 14.27% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 1437 | $0.00 | 14,378.0000 | 79,773,004 | 9.09% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | M | Restricted Stock Unit (RSU) | 6062 | $0.00 | 84,876.0000 | 79,773,004 | 6.67% | 0.01% |
| May 10, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 10000 | $16.37 | 2,164,662.0000 | 79,773,004 | 0.46% | 0.01% |
| April 18, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 10000 | $16.02 | 2,174,662.0000 | 79,773,004 | 0.46% | 0.01% |
| March 25, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 10000 | $16.01 | 2,184,662.0000 | 79,773,004 | 0.46% | 0.01% |
| March 11, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 30000 | $15.24 | 2,194,662.0000 | 79,773,004 | 1.35% | 0.04% |
| Feb. 27, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF R&D | S | Common Stock | 20000 | $16.11 | 2,224,662.0000 | 79,773,004 | 0.89% | 0.03% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | M | Common Stock | 1187 | $0.00 | 2,239,421.0000 | 79,773,004 | 0.05% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | M | Common Stock | 1437 | $0.00 | 2,240,858.0000 | 79,773,004 | 0.06% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | M | Common Stock | 6062 | $0.00 | 2,246,920.0000 | 79,773,004 | 0.27% | 0.01% |
| Feb. 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | S | Common Stock | 2258 | $15.25 | 2,244,662.0000 | 79,773,004 | 0.10% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | M | Restricted Stock Unit (RSU) | 1187 | $0.00 | 8,317.0000 | 79,773,004 | 12.49% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | M | Restricted Stock Unit (RSU) | 1437 | $0.00 | 15,815.0000 | 79,773,004 | 8.33% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | HEAD OF RESEARCH AND DEVELOPME | M | Restricted Stock Unit (RSU) | 6062 | $0.00 | 90,938.0000 | 79,773,004 | 6.25% | 0.01% |
| Jan. 5, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | Head of Research and Developme | A | Stock Option (right to buy Common Stock) | 148000 | $0.00 | 148,000.0000 | 79,773,004 | 9999.99% | 0.19% |
| Jan. 5, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | Blackman Samuel C. | Head of Research and Developme | A | Restricted Stock Units | 97000 | $0.00 | 97,000.0000 | 79,773,004 | 9999.99% | 0.12% |